Northern Trust Corp Seelos Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.16 - $1.64 $51 - $531	-324 Reduced 0.16%	205,847 $37,000
Q2 2023 Aug 11, 2023	BUY	$0.66 - $1.22 $6,592 - $12,186	9,989 Added 5.09%	206,171 $247,000
Q1 2023 May 15, 2023	BUY	$0.59 - $1.04 $7,202 - $12,695	12,207 Added 6.64%	196,182 $135,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $278.68 $3,479 - $1.49 Million	5,353 Added 3.0%	183,975 $189,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $351,987 - $641,859	-690,171 Reduced 79.44%	178,622 $121,000
Q1 2022 May 13, 2022	SELL	$0.84 - $1.71 $30,646 - $62,387	-36,484 Reduced 4.03%	868,793 $728,000
Q4 2021 Feb 08, 2022	SELL	$1.59 - $2.38 $12,063 - $18,057	-7,587 Reduced 0.83%	905,277 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $258,245 - $441,615	152,808 Added 20.1%	912,864 $2.2 Million
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $1.68 Million - $4.03 Million	637,626 Added 520.81%	760,056 $2.01 Million
Q1 2021 May 12, 2021	BUY	$1.35 - $4.99 $43,588 - $161,117	32,288 Added 35.82%	122,430 $611,000
Q4 2020 Feb 11, 2021	BUY	$0.74 - $2.01 $7,782 - $21,139	10,517 Added 13.21%	90,142 $142,000
Q3 2020 Nov 16, 2020	SELL	$0.6 - $1.25 $10,844 - $22,592	-18,074 Reduced 18.5%	79,625 $75,000
Q2 2020 Aug 14, 2020	BUY	$0.42 - $1.51 $28,872 - $103,801	68,743 Added 237.41%	97,699 $99,000
Q1 2020 May 14, 2020	BUY	$0.47 - $1.56 $4,558 - $15,128	9,698 Added 50.36%	28,956 $14,000
Q4 2019 Feb 14, 2020	SELL	$0.72 - $1.52 $5,630 - $11,886	-7,820 Reduced 28.88%	19,258 $26,000
Q3 2019 Nov 13, 2019	BUY	$0.92 - $2.15 $14,375 - $33,595	15,626 Added 136.45%	27,078 $25,000
Q2 2019 Aug 13, 2019	BUY	$2.11 - $3.3 $24,163 - $37,791	11,452 New	11,452 $25,000

Others Institutions Holding SEEL

# of Institutions

Shares Held

40.5K

Call Options Held

Put Options Held

Asset Management Corp

40.5K
Shares

$15,795
0.02% of portfolio

View Full List

About SEELOS THERAPEUTICS, INC.

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $41.6M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

More about SEEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account